NFKB1 and hepatocellular carcinoma: Emodin suppresses ATP-induced cell proliferation and migration through inhibiting NF-κB activation in human NSCLC A549 cells [380], and induces apoptosis through cell cycle arrest and ROS production in human hepatocellular carcinoma HepaRG cells [381].